open access
Ovarian metastasis in a patient with neuroendocrine tumour of the small intestine
, 2, 1, 1, 1
Affiliations- Clinical Department of Perinatology and Oncological Gynaecology, Medical University of Silesia, Sosnowiec, Poland
- Department of Endocrinology and Neuroendocrine Tumours, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland
open access
Abstract
No required for Clinical Vignette.
Abstract
No required for Clinical Vignette.
Keywords
ovarian metastatic NET; carcinoid syndrome; somatostatin analogue; peptide receptor radionuclide therapy
About this articleTitle
Ovarian metastasis in a patient with neuroendocrine tumour of the small intestine
Journal
Issue
Article type
Clinical vignette
Published online
2023-12-11
Page views
423
Article views/downloads
200
DOI
Bibliographic record
Endokrynol Pol 2023;74(6).
Keywords
ovarian metastatic NET
carcinoid syndrome
somatostatin analogue
peptide receptor radionuclide therapy
Authors
Tomasz Krzysztof Bryś
Violetta Rosiek
Beata Rembielak-Stawecka
Marek Rajca
Marek Kudła
References (5)- Kos-Kudła B, Foltyn W, Malczewska A, et al. Update of the diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours) . Endokrynol Pol. 2022; 73(3): 387–454.
- Huang Wu, Bao Y, Luo X, et al. Neuroendocrine neoplasms of the ovary: an analysis of clinicopathological characteristics and prognosis with a focus on histological grading. Endocrine. 2022; 77(1): 188–198.
- Pang Li, Guo Z. Primary neuroendocrine tumors of the ovary: Management and outcomes. Cancer Med. 2021; 10(23): 8558–8569.
- Mulders MCF, de Lussanet de la Sablonière QG, van Velthuysen MLF, et al. Unfavorable biological behavior and treatment response of neuroendocrine ovarian metastases of midgut neuroendocrine tumors. Endocr Relat Cancer. 2023; 30(8).
- Bednarczuk T, Zemczak A, Bolanowski M, et al. Neuroendocrine neoplasms of the small intestine and the appendix — update of the diagnostic and therapeutic guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol. 2022; 73(3): 549–583.
